Ke‐Wei Zhu

730 total citations
31 papers, 516 citations indexed

About

Ke‐Wei Zhu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ke‐Wei Zhu has authored 31 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Ke‐Wei Zhu's work include Acute Myeloid Leukemia Research (7 papers), COVID-19 Clinical Research Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Ke‐Wei Zhu is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), COVID-19 Clinical Research Studies (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Ke‐Wei Zhu collaborates with scholars based in China, United Kingdom and United States. Ke‐Wei Zhu's co-authors include Wanchun Wang, Chen Ding, Yejia Zhang, Xiaoping Chen, Shan Cao, Yan Han, Xiaoqing Yuan, Gan Zhou, Yonglong Yang and Xielan Zhao and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Materials Chemistry A.

In The Last Decade

Ke‐Wei Zhu

29 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke‐Wei Zhu China 13 268 156 75 66 65 31 516
Qun Hu China 11 278 1.0× 148 0.9× 137 1.8× 65 1.0× 118 1.8× 78 628
Marco Benati Italy 15 286 1.1× 221 1.4× 98 1.3× 43 0.7× 63 1.0× 36 697
Hong Yue United States 15 275 1.0× 141 0.9× 82 1.1× 50 0.8× 29 0.4× 28 638
Xi Xie China 14 271 1.0× 141 0.9× 75 1.0× 39 0.6× 52 0.8× 41 714
Yuan Sheng China 13 378 1.4× 214 1.4× 161 2.1× 80 1.2× 44 0.7× 38 775
Zhi Zuo China 14 181 0.7× 77 0.5× 34 0.5× 48 0.7× 45 0.7× 43 501
Jun Xue China 14 187 0.7× 63 0.4× 72 1.0× 122 1.8× 26 0.4× 45 657
Benjamin L. Schlechter United States 12 152 0.6× 106 0.7× 200 2.7× 92 1.4× 49 0.8× 51 655
Kehua Wu United States 11 231 0.9× 82 0.5× 210 2.8× 78 1.2× 20 0.3× 23 542
Huan Lin China 9 152 0.6× 62 0.4× 71 0.9× 37 0.6× 35 0.5× 16 434

Countries citing papers authored by Ke‐Wei Zhu

Since Specialization
Citations

This map shows the geographic impact of Ke‐Wei Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke‐Wei Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke‐Wei Zhu more than expected).

Fields of papers citing papers by Ke‐Wei Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke‐Wei Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke‐Wei Zhu. The network helps show where Ke‐Wei Zhu may publish in the future.

Co-authorship network of co-authors of Ke‐Wei Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke‐Wei Zhu. A scholar is included among the top collaborators of Ke‐Wei Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke‐Wei Zhu. Ke‐Wei Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhu, Ke‐Wei, Zhe Yang, Guili Liu, et al.. (2024). Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants. Scientific Reports. 14(1). 30037–30037.
3.
4.
Xiao, Bing, et al.. (2024). Structural Safety Analysis of Steel-Concrete Composite Single-Wall Caisson Cofferdams for Deep-Water Bridge Piers. Soil Mechanics and Foundation Engineering. 61(5). 469–475.
5.
Zhu, Ke‐Wei, et al.. (2023). Esophageal Ulcer After Intravitreal Ranibizumab Injection in a Patient With Age-Related Macular Degeneration. Gastroenterology Research. 16(2). 118–124. 1 indexed citations
6.
Zhu, Ke‐Wei. (2023). Deuremidevir and Simnotrelvir–Ritonavir for the Treatment of COVID-19. ACS Pharmacology & Translational Science. 6(9). 1306–1309. 29 indexed citations
7.
Zhu, Ke‐Wei. (2023). Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage?. Human Vaccines & Immunotherapeutics. 19(2). 2229704–2229704. 6 indexed citations
8.
9.
Zhu, Ke‐Wei, Sibo Cheng, Nina M. Kovalchuk, et al.. (2023). Analyzing drop coalescence in microfluidic devices with a deep learning generative model. Physical Chemistry Chemical Physics. 25(23). 15744–15755. 6 indexed citations
10.
Li, Wenzhao, et al.. (2023). The Nrf2/HMGB1/NF-κB axis modulates chondrocyte apoptosis and extracellular matrix degradation in osteoarthritis. Acta Biochimica et Biophysica Sinica. 55(5). 818–830. 9 indexed citations
11.
Zhu, Ke‐Wei. (2023). Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials. Frontiers in Pharmacology. 14. 1228548–1228548. 6 indexed citations
12.
Zhu, Ke‐Wei, Zhangnan Li, Mengxuan Yu, et al.. (2022). Multiple boosting Janus membranes synergized with Li-rich PAF-6 and carbon nanoparticles for high performance lithium–sulfur batteries. Journal of Materials Chemistry A. 10(45). 24106–24114. 14 indexed citations
13.
Zhu, Ke‐Wei, et al.. (2022). Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single‐dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions. Clinical Pharmacology in Drug Development. 11(8). 987–996. 4 indexed citations
14.
Chen, Peng, Yonglong Yang, Ke‐Wei Zhu, et al.. (2021). TBC1D16 predicts chemosensitivity and prognosis in adult acute myeloid leukemia (AML) patients. European Journal of Pharmacology. 895. 173894–173894. 5 indexed citations
15.
16.
Liu, Jie, Wei Ma, Guodong Wang, et al.. (2021). Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway. Annals of Translational Medicine. 9(22). 1694–1694. 42 indexed citations
17.
Qin, Xia, et al.. (2020). Erdheim-Chester disease with asymmetric talus involvement: A case report. World Journal of Clinical Cases. 8(3). 614–623. 2 indexed citations
18.
Tang, Qi, Qi Yuan, Hui Li, et al.. (2018). miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin. Biochemical and Biophysical Research Communications. 497(3). 827–834. 35 indexed citations
19.
Zhu, Ke‐Wei & Wanchun Wang. (2015). Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1. Tumor Biology. 37(4). 4373–4382. 72 indexed citations
20.
Ding, Chen, Yejia Zhang, Ke‐Wei Zhu, & Wanchun Wang. (2013). A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma. Tumor Biology. 34(3). 1895–1899. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qun Hu Breakdown of academic impact, for papers by Marco Benati Breakdown of academic impact, for papers by Hong Yue Breakdown of academic impact, for papers by Xi Xie Breakdown of academic impact, for papers by Yuan Sheng Breakdown of academic impact, for papers by Zhi Zuo Breakdown of academic impact, for papers by Jun Xue Breakdown of academic impact, for papers by Benjamin L. Schlechter Breakdown of academic impact, for papers by Kehua Wu Breakdown of academic impact, for papers by Huan Lin
Rankless by CCL
2026